tradmap

AMSF Financials AMERISAFE INC

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has declined 1.3% per year over the past 5 years.
  • Net income has grown slower than revenue (-11.5% vs -1.3% per year).
  • Free cash flow has declined 32.2% per year over the past 5 years.

Shareholder returns

  • Dividends have been paid for 15 consecutive years, consuming 133.1% of earnings and 702.8% of free cash flow.
  • The dividend has declined 6.7% per year over the past 5 years.
Revenue & net income
$0 $202M $404M 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
0% 13% 26% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Return on equity & assets (ROE / ROA)
0% 11% 22% 2011 2013 2015 2017 2019 2021 2023 2025
ROEROA
Free cash flow (CFO − capex)
$0 $65M $130M 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $62M $123M 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$113M $9M $131M $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2025 $317M $47M 0.0% 0.0% 18.7% 4.2% $9M — $62M
2024 $309M $55M 0.0% 0.0% 21.5% 4.8% $23M — $44M
2023 $307M $62M 0.0% 0.0% 21.2% 5.1% $29M — $39M
2022 $295M $56M 0.0% 0.0% 17.5% 4.4% $26M — $61M
2021 $316M $66M 0.0% 0.0% 16.5% 4.7% $37M — $71M
2020 $339M $87M 0.0% 0.0% 19.7% 5.9% $62M — $62M
2019 $370M $93M 0.0% 0.0% 21.5% 6.2% $78M — $44M
2018 $378M $72M 0.0% 0.0% 17.5% 4.7% $97M — $40M
2017 $375M $46M 0.0% 0.0% 10.9% 3.0% $130M — $56M
2016 $397M $78M 0.0% 0.0% 17.1% 5.1% $113M — $59M
2015 $401M $70M 0.0% 0.0% 15.5% 4.7% — — $69M
2014 $404M $54M 0.0% 0.0% 12.0% 3.7% — — $91M
2013 $356M $44M 0.0% 0.0% 10.5% 3.3% — — $123M
2012 $321M $29M 0.0% 0.0% 7.7% 2.4% $80M — $93M
2011 $281M $24M 0.0% 0.0% 6.9% 2.1% $43M — $46M

Valuation over time

How the market has priced AMSF against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 9.3 18.5 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/E
Price / sales (P/S)
0.0 1.8 3.6 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/S
Dividend yield (%)
0.0 8.2 16.4 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
Dividend yield %

Frequently asked questions

Is AMSF growing its revenue and profit?

Over the past 5 years, AMERISAFE INC's revenue has declined 1.3% per year, and net income declined 11.5% per year. These are computed facts, not advice.

How much debt does AMSF have?

As of FY2025, AMERISAFE INC reported — of total debt against $62M of cash.

What is AMSF's profit margin?

In FY2025, gross margin was —, operating margin —, and net margin 14.8%.

What is AMSF's P/E ratio?

AMERISAFE INC's P/E (TTM) is 9.50 as of the 2026-11-02 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the AMSF stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 8.1× as of Nov '26) can differ. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.